BNP Paribas Financial Markets’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.9M | Buy |
440,633
+77,797
| +21% | +$3.26M | 0.01% | 1119 |
|
|
2026
Q1 | $11.7M | Buy |
362,836
+10,215
| +3% | +$378K | 0.01% | 1483 |
|
|
2025
Q4 | $14.8M | Buy |
352,621
+281,079
| +393% | +$11.3M | 0.01% | 1371 |
|
|
2025
Q3 | $2.46M | Buy |
71,542
+36,215
| +103% | +$1.04M | ﹤0.01% | 2472 |
|
|
2025
Q2 | $955K | Buy |
35,327
+5,693
| +19% | +$165K | ﹤0.01% | 2939 |
|
|
2025
Q1 | $879K | Sell |
29,634
-13,104
| -31% | -$499K | ﹤0.01% | 2878 |
|
|
2024
Q4 | $1.69M | Sell |
42,738
-55,684
| -57% | -$2.11M | ﹤0.01% | 2465 |
|
|
2024
Q3 | $3.35M | Buy |
98,422
+80,145
| +439% | +$2.25M | ﹤0.01% | 1737 |
|
|
2024
Q2 | $396K | Sell |
18,277
-39,519
| -68% | -$831K | ﹤0.01% | 2783 |
|
|
2024
Q1 | $1.28M | Sell |
57,796
-89
| -0.2% | -$2.17K | ﹤0.01% | 2342 |
|
|
2023
Q4 | $1.59M | Sell |
57,885
-1,256
| -2% | -$30.3K | ﹤0.01% | 2106 |
|
|
2023
Q3 | $1.32M | Buy |
59,141
+5,106
| +9% | +$131K | ﹤0.01% | 2144 |
|
|
2023
Q2 | $1.38M | Sell |
54,035
-28,440
| -34% | -$689K | ﹤0.01% | 1990 |
|
|
2023
Q1 | $1.84M | Buy |
82,475
+26,919
| +48% | +$651K | ﹤0.01% | 1883 |
|
|
2022
Q4 | $1.32M | Sell |
55,556
-71,179
| -56% | -$1.65M | ﹤0.01% | 2007 |
|
|
2022
Q3 | $2.1M | Buy |
126,735
+108,635
| +600% | +$2.44M | ﹤0.01% | 1926 |
|
|
2022
Q2 | $360K | Buy |
18,100
+6,405
| +55% | +$129K | ﹤0.01% | 2826 |
|
|
2022
Q1 | $322K | Sell |
11,695
-14,270
| -55% | -$408K | ﹤0.01% | 2963 |
|
|
2021
Q4 | $1.07M | Buy |
25,965
+8,811
| +51% | +$389K | ﹤0.01% | 2544 |
|
|
2021
Q3 | $797K | Buy |
17,154
+14,679
| +593% | +$641K | ﹤0.01% | 2502 |
|
|
2021
Q2 | $99K | Sell |
2,475
-5,690
| -70% | -$243K | ﹤0.01% | 3045 |
|
|
2021
Q1 | $439K | Sell |
8,165
-15,672
| -66% | -$903K | ﹤0.01% | 2640 |
|
|
2020
Q4 | $1.17M | Sell |
23,837
-16,748
| -41% | -$776K | ﹤0.01% | 1919 |
|
|
2020
Q3 | $1.32M | Buy |
40,585
+3,620
| +10% | +$115K | ﹤0.01% | 1686 |
|
|
2020
Q2 | $957K | Sell |
36,965
-19,793
| -35% | -$493K | ﹤0.01% | 1827 |
|
|
2020
Q1 | $1.38M | Buy |
56,758
+30,886
| +119% | +$777K | ﹤0.01% | 1703 |
|
|
2019
Q4 | $722K | Buy |
25,872
+402
| +2% | +$10.4K | ﹤0.01% | 2225 |
|
|
2019
Q3 | $611K | Buy |
25,470
+22,329
| +711% | +$594K | ﹤0.01% | 2091 |
|
|
2019
Q2 | $89.5K | Sell |
3,141
-2,747
| -47% | -$68.6K | ﹤0.01% | 3099 |
|
|
2019
Q1 | $147K | Buy |
5,888
+5,879
| +65,322% | +$112K | ﹤0.01% | 2879 |
|
|
2018
Q4 | $113 | Sell |
9
-692
| -99% | -$8.18K | ﹤0.01% | 4168 |
|
|
2018
Q3 | $6.7K | Hold |
701
| – | – | ﹤0.01% | 3924 |
|
|
2018
Q2 | $6.55K | Sell |
701
-4,338
| -86% | -$30.5K | ﹤0.01% | 3969 |
|
|
2018
Q1 | $28K | Buy |
5,039
+406
| +9% | +$2.51K | ﹤0.01% | 3827 |
|
|
2017
Q4 | $30.3K | Buy |
4,633
+2,238
| +93% | +$16.6K | ﹤0.01% | 3879 |
|
|
2017
Q3 | $21K | Sell |
2,395
-53
| -2% | -$431 | ﹤0.01% | 3570 |
|
|
2017
Q2 | $20.4K | Buy |
2,448
+1,669
| +214% | +$13.6K | ﹤0.01% | 3653 |
|
|
2017
Q1 | $7.15K | Sell |
779
-845
| -52% | -$6.91K | ﹤0.01% | 3234 |
|
|
2016
Q4 | $12.6K | Buy |
1,624
+668
| +70% | +$5K | ﹤0.01% | 3356 |
|
|
2016
Q3 | $7.28K | Buy |
956
+398
| +71% | +$2.25K | ﹤0.01% | 3307 |
|
|
2016
Q2 | $2.81K | Buy |
+558
| New | +$2.99K | ﹤0.01% | 3423 |
|
|
2016
Q1 | – | Sell |
-3,084
| Closed | -$22.2K | – | 3079 |
|
|
2015
Q4 | $22.2K | Buy |
3,084
+49
| +2% | +$330 | ﹤0.01% | 3254 |
|
|
2015
Q3 | $14.2K | Buy |
3,035
+1,913
| +170% | +$18.2K | ﹤0.01% | 3379 |
|
|
2015
Q2 | $12.5K | Buy |
1,122
+978
| +679% | +$9.63K | ﹤0.01% | 3276 |
|
|
2015
Q1 | $1.05K | Buy |
+144
| New | +$1.18K | ﹤0.01% | 3548 |
|
|
2014
Q4 | – | Sell |
-55
| Closed | -$536 | – | 3166 |
|
|
2014
Q3 | $536 | Buy |
+55
| New | +$722 | ﹤0.01% | 4028 |
|
Other funds holding VCYT
AIM
BNP Paribas Financial Markets's VCYT Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Veracyte (VCYT) stake by 21% in Q2 2026, buying an estimated $3.26M and bringing the position to 440,633 shares worth $25.9M. The position accounts for 0.01% of the portfolio, ranked #1119.
BNP Paribas Financial Markets first reported a position in VCYT in Q3 2014 and has held it in 46 quarters since. 349 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- BNP Paribas Financial Markets held 440,633 shares of Veracyte worth $25.9M as of Q2 2026.
- BNP Paribas Financial Markets bought 77,797 Veracyte shares in Q2 2026, an estimated $3.26M.
- Veracyte made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1119 holding.
- BNP Paribas Financial Markets first reported a position in Veracyte in Q3 2014 and has held it in 46 quarters since.
- 349 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.